May 11, 2020 / 12:16 PM / 15 days ago

BRIEF-Biospecifics Reports First Quarter 2020 Financial And Operating Results

Biospecifics Technologies Corp:

* BIOSPECIFICS REPORTS FIRST QUARTER 2020 FINANCIAL AND OPERATING RESULTS

* Q1 REVENUE $9.7 MILLION VERSUS $8.1 MILLION

* INITIATION OF CCH STUDIES FOR PLANTAR FIBROMATOSIS AND ADHESIVE CAPSULITIS IN 2H20

* XIAFLEX REVENUES ARE EXPECTED TO DECLINE IN Q2 OF 2020

* FULL YEAR 2020 XIAFLEX REVENUES ARE EXPECTED TO BE LOWER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below